Tags
You are here: Home
Thermo Fisher Scientific
23.05.2011
Thermo said on Thursday that the deal to buy Sweden-based Phadia from European private equity firm Cinven would immediately add to earnings. The deal is expected to be completed in the fourth quarter and add 26 to 30 cents per share to 2012 earnings. more19.05.2011
more02.03.2010
02.03.2010
01.03.2010
Scientific, said it hired Goldman Sachs as an advisor in evaluating "strategic alternatives." A source familiar with the situation told Reuters on Monday Thermo Fisher Scientific has offered to buy Millipore. Millipore said it not has set a definitive timetable for completion of its evaluation. more
Thermo Fisher To Buy Phadia For $3.5 Billion
Laboratory equipment company Thermo Fisher Scientific Inc agreed to acquire private-equity owned Phadia, maker of allergy and autoimmune tests, for about $3.5 billion to expand in specialty diagnostics.Thermo said on Thursday that the deal to buy Sweden-based Phadia from European private equity firm Cinven would immediately add to earnings. The deal is expected to be completed in the fourth quarter and add 26 to 30 cents per share to 2012 earnings. more19.05.2011
Bidders Emerge For Gen-Probe, Phadia
Bidders emerged for allergy-testing company Phadia and diagnostic test-maker Gen-Probe, according to The Wall Street Journal. Laboratory equipment company Thermo Fisher Scientific is a leading contender for privately owned Phadia, and is involved in the auction for Gen-Probe, the newspaper reported in its online edition. Phadia could fetch as much as $3 billion in a sale, while Gen-Probe has a market capitalization of $3.8 billion. more16.05.2011EU Approves Thermo Fisher's Dionex Buy
Thermo Fisher Scientific, the world's largest maker of scientific instruments, secured EU regulatory clearance on Friday to buy chromatography systems maker Dionex Corp for $2.1 billion. Thermo Fisher unveiled the deal in December last year and it will reinforce its presence in Asia and strengthen its lab equipment operations. more13.01.2011Thermo Fisher To Pursue Sale Of Lab-Testing Units
Thermo Fisher Scientific, a maker of scientific instruments, is pursuing a sale of two lab-testing divisions that may fetch up to $1 billion, Bloomberg said, citing three people familiar with the matter. Thermo Fisher has hired Goldman Sachs to handle the sale of Athena Diagnostics, which may be sold for $600-$700 million, and Barclays Capital to help it sell Lancaster Labs, which may fetch $200-$300 million, Bloomberg said. more14.12.2010Roundup: Deals of the Day
• Private equity firm Bain Capital agreed to buy Dutch specialty chemical distributor IMCD, in a deal that people familiar with the matter said valued the business at close to €650 million. • Thermo Fisher Scientific, the world's largest maker of scientific instruments, said it would buy Dionex for $2.1 billion to broaden its lab equipment and environmental safety offerings and boost its presence in Asia. more08.09.2010Thermo Fisher Scientific Adds Vialis Paperless Lab Solutions to its Global Partner Alliance
Thermo Fisher Scientific today announced that it has extended its reach across Central Europe by making Vialis the latest member of its informatics global partner alliance. Vialis, based in Switzerland, will provide local services and support for the full range of thermo scientific informatics solutions, including laboratory information management systems, chromatography data systems, electronic laboratory notebooks and spectroscopy software, as well as comprehensive laboratory automation and integration solutions.more02.03.2010
Is Merck KGaA's $6 Billion Bid for Millipore Too Costly?
Germany's family-controlled Merck KGaA agreed to buy U.S. biotech tool maker Millipore for $6 billion to diversify away from its embattled drugs business. While analysts said the deal made strategic sense, they were also concerned Merck may be paying too much for the maker of filters and purifiers for laboratory water and other materials used in making biotechnology drugs. moreUpdate: Merck KGaA Buys Millipore to Stabilize Business
Merck KGaA's agreed $6 billion cash purchase of U.S. biotech tool maker Millipore buoyed the German drugmaker's share on Monday as it diversified away from its embattled pharmaceuticals business. Merck, which makes the multiple sclerosis drug Rebif and owns the rights to cancer drug Erbitux in Europe, agreed on Sunday to buy Millipore in a deal that boosts its lab equipment business. moreGermany's Merck to Buy Millipore in $6 Billion Deal
Germany's Merck KGaA on Sunday said it agreed to buy U.S. biotech tool maker Millipore for around $6 billion in cash, as the company looks to build its lab equipment business. Merck, the world's largest maker of chemicals for flat-panel displays, said late on Sunday it agreed to acquire Millipore for $107 per share in cash, valuing the deal at around $7.2 billion including net debt. more24.02.2010Millipore Says Evaluating ‘Strategic Alternatives’
Millipore, which is under a $6 billion takeover offer from U.S. laboratory equipment maker Thermo FisherScientific, said it hired Goldman Sachs as an advisor in evaluating "strategic alternatives." A source familiar with the situation told Reuters on Monday Thermo Fisher Scientific has offered to buy Millipore. Millipore said it not has set a definitive timetable for completion of its evaluation. more
- Legal
- Help
- Participate
- Related Publications